These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 22257645

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Impact of Adrenal Hormone Supplementation on Bone Geometry in Growing Teens With Anorexia Nervosa.
    DiVasta AD, Feldman HA, O'Donnell JM, Long J, Leonard MB, Gordon CM.
    J Adolesc Health; 2019 Oct; 65(4):462-468. PubMed ID: 31227390
    [Abstract] [Full Text] [Related]

  • 4. Effects of oral dehydroepiandrosterone on bone density in young women with anorexia nervosa: a randomized trial.
    Gordon CM, Grace E, Emans SJ, Feldman HA, Goodman E, Becker KA, Rosen CJ, Gundberg CM, LeBoff MS.
    J Clin Endocrinol Metab; 2002 Nov; 87(11):4935-41. PubMed ID: 12414853
    [Abstract] [Full Text] [Related]

  • 5. Magnetic resonance imaging and spectroscopy evidence of efficacy for adrenal and gonadal hormone replacement therapy in anorexia nervosa.
    Vajapeyam S, Ecklund K, Mulkern RV, Feldman HA, O'Donnell JM, DiVasta AD, Rosen CJ, Gordon CM.
    Bone; 2018 May; 110():335-342. PubMed ID: 29496516
    [Abstract] [Full Text] [Related]

  • 6. The effect of different contraceptive treatments on the serum concentration of dehydroepiandrosterone sulfate.
    Klove KL, Roy S, Lobo RA.
    Contraception; 1984 Apr; 29(4):319-24. PubMed ID: 6235099
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Restoring testosterone levels by adding dehydroepiandrosterone to a drospirenone containing combined oral contraceptive: I. Endocrine effects.
    Zimmerman Y, Foidart JM, Pintiaux A, Minon JM, Fauser BC, Cobey K, Coelingh Bennink HJ.
    Contraception; 2015 Feb; 91(2):127-33. PubMed ID: 25604900
    [Abstract] [Full Text] [Related]

  • 10. The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women.
    Morales AJ, Haubrich RH, Hwang JY, Asakura H, Yen SS.
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):421-32. PubMed ID: 9876338
    [Abstract] [Full Text] [Related]

  • 11. Dehydroepiandrosterone status and efficacy of dehydroepiandrosterone supplementation for bone health in anorexia nervosa: A systematic review and meta-analysis.
    Lin J, Kao TW, Cheng YC, Fan KC, Huang YC, Liu CW.
    Int J Eat Disord; 2022 Jun; 55(6):733-746. PubMed ID: 35460091
    [Abstract] [Full Text] [Related]

  • 12. Maintaining physiological testosterone levels by adding dehydroepiandrosterone to combined oral contraceptives: I. Endocrine effects.
    Coelingh Bennink HJT, Zimmerman Y, Laan E, Termeer HMM, Appels N, Albert A, Fauser BCJM, Thijssen JHH, van Lunsen RHW.
    Contraception; 2017 Nov; 96(5):322-329. PubMed ID: 27393080
    [Abstract] [Full Text] [Related]

  • 13. Restoring testosterone levels by adding dehydroepiandrosterone to a drospirenone containing combined oral contraceptive: II. Clinical effects.
    Zimmerman Y, Foidart JM, Pintiaux A, Minon JM, Fauser BC, Cobey K, Coelingh Bennink HJ.
    Contraception; 2015 Feb; 91(2):134-42. PubMed ID: 25496917
    [Abstract] [Full Text] [Related]

  • 14. Pituitary function and DHEA-S in male acne and DHEA-S, prolactin and cortisol before and after oral contraceptive treatment in female acne.
    Palatsi R, Reinilä M, Kivinén S.
    Acta Derm Venereol; 1986 Feb; 66(3):225-30. PubMed ID: 2426899
    [Abstract] [Full Text] [Related]

  • 15. The pharmacokinetics and pharmacodynamics of dehydroepiandrosterone during use of an ethinylestradiol- and drospirenone-containing oral contraceptive.
    Zimmerman Y, Coelingh Bennink HJ, Wouters W, Ebes F, Fauser BC.
    Eur J Contracept Reprod Health Care; 2013 Dec; 18(6):489-500. PubMed ID: 23944295
    [Abstract] [Full Text] [Related]

  • 16. Effect of Transdermal Estradiol and Insulin-like Growth Factor-1 on Bone Endpoints of Young Women With Anorexia Nervosa.
    Singhal V, Bose A, Slattery M, Haines MS, Goldstein MA, Gupta N, Brigham KS, Ebrahimi S, Javaras KN, Bouxsein ML, Eddy KT, Miller KK, Schoenfeld D, Klibanski A, Misra M.
    J Clin Endocrinol Metab; 2021 Jun 16; 106(7):2021-2035. PubMed ID: 33693703
    [Abstract] [Full Text] [Related]

  • 17. The effect of estrogen-progestin treatment on bone mineral density in anorexia nervosa.
    Golden NH, Lanzkowsky L, Schebendach J, Palestro CJ, Jacobson MS, Shenker IR.
    J Pediatr Adolesc Gynecol; 2002 Jun 16; 15(3):135-43. PubMed ID: 12106749
    [Abstract] [Full Text] [Related]

  • 18. Effects of a triphasic combination oral contraceptive containing norgestimate/ethinyl estradiol on biochemical markers of bone metabolism in young women with osteopenia secondary to hypothalamic amenorrhea.
    Grinspoon SK, Friedman AJ, Miller KK, Lippman J, Olson WH, Warren MP.
    J Clin Endocrinol Metab; 2003 Aug 16; 88(8):3651-6. PubMed ID: 12915650
    [Abstract] [Full Text] [Related]

  • 19. Dehydroepiandrosterone treatment effects on weight, bone density, bone metabolism and mood in women suffering from anorexia nervosa-a pilot study.
    Bloch M, Ish-Shalom S, Greenman Y, Klein E, Latzer Y.
    Psychiatry Res; 2012 Dec 30; 200(2-3):544-9. PubMed ID: 22858403
    [Abstract] [Full Text] [Related]

  • 20. Dehydroepiandrosterone replacement in women with adrenal insufficiency: effects on body composition, serum leptin, bone turnover, and exercise capacity.
    Callies F, Fassnacht M, van Vlijmen JC, Koehler I, Huebler D, Seibel MJ, Arlt W, Allolio B.
    J Clin Endocrinol Metab; 2001 May 30; 86(5):1968-72. PubMed ID: 11344193
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.